Search research articles
Contact Us
Filters
Showing results (341-350 of 845) with videos related to
Page
of 85
Sort By:
The Urologic Clinics of North America
|
November 27, 2012
Urologic Clinics of North America. Multidisciplinary management of urinary stone disease. Foreword
Samir S Taneja
The Journal of Urology
|
December 23, 2018
Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Samir S Taneja
The Journal of Urology
|
November 12, 2019
Re: Oncological and Quality-of-Life Outcomes following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-Monitored Prospective Cohort
Samir S Taneja
The Journal of Urology
|
December 13, 2019
Re: Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a De Novo Low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Samir S Taneja
European Urology
|
June 20, 2024
Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-Term Oncologic Outcomes in a Shared Equal-Access Health System
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Germline DNA-Repair Gene Mutations and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Effects of Pathological Upstaging or Upgrading on Metastasis and Cancer-Specific Mortality in Men with Clinical Low-Risk Prostate Cancer
Samir S Taneja
The Journal of Urology
|
October 19, 2016
Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial
Samir S Taneja
Page
of 85
Search research articles
Search
Showing results (341-350 of 845) with videos related to
Sort By:
Page
of 85
The Urologic Clinics of North America
|
November 27, 2012
Urologic Clinics of North America. Multidisciplinary management of urinary stone disease. Foreword
Samir S Taneja
The Journal of Urology
|
December 23, 2018
Re: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Samir S Taneja
The Journal of Urology
|
November 12, 2019
Re: Oncological and Quality-of-Life Outcomes following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-Monitored Prospective Cohort
Samir S Taneja
The Journal of Urology
|
December 13, 2019
Re: Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a De Novo Low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Samir S Taneja
European Urology
|
June 20, 2024
Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features
Samir S Taneja
The Journal of Urology
|
November 11, 2018
Re: Validation of the 2015 Prostate Cancer Grade Groups for Predicting Long-Term Oncologic Outcomes in a Shared Equal-Access Health System
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Germline DNA-Repair Gene Mutations and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide
Samir S Taneja
The Journal of Urology
|
October 27, 2018
Re: Effects of Pathological Upstaging or Upgrading on Metastasis and Cancer-Specific Mortality in Men with Clinical Low-Risk Prostate Cancer
Samir S Taneja
The Journal of Urology
|
October 19, 2016
Re: Hypofractionated Radiotherapy versus Conventionally Fractionated Radiotherapy for Patients with Intermediate-Risk Localised Prostate Cancer: 2-Year Patient-Reported Outcomes of the Randomised, Non-Inferiority, Phase 3 CHHiP Trial
Samir S Taneja
Page
of 85